Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Sep;78(3):674–679. doi: 10.1172/JCI112626

Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.

L Arnolda, B P McGrath, M Cocks, C I Johnston
PMCID: PMC423649  PMID: 3528220

Abstract

Vasopressin's role as a vasoconstrictor in chronic heart failure, was examined in rabbits with adriamycin cardiomyopathic congestive heart failure. Chronic adriamycin treatment resulted in a decrease in cardiac output (829 +/- 38-610 +/- 36 ml/min, P less than 0.005) and blood pressure (83 +/- 2-76 +/- 3 mmHg, P less than 0.01), and an increase in peripheral resistance (8,377 +/- 381-10,170 +/- 657 dyn-s-cm-5, P less than 0.05). Plasma renin activity (4.7 +/- 0.6-10.9 +/- 2.8 ng angiotensin I/ml X h) and norepinephrine (0.7 +/- 0.1-1.3 +/- 0.2 pmol/ml, P less than 0.05) increased while plasma vasopressin levels did not change. Vasopressin infusion, however, produced significantly greater increases in peripheral resistance in animals with heart failure than in controls. Moreover, a specific vasopressin vascular antagonist reduced blood pressure (7 +/- 3%) and peripheral resistance (14 +/- 4%) and increased cardiac output (10 +/- 3%) in animals with heart failure but had no cardiovascular effects in normal rabbits. These results suggest that vascular sensitivity to vasopressin is increased in heart failure, and that it contributes significantly to the increased afterload in heart failure despite normal plasma levels. In this model of severe, chronic heart failure the sympathetic, renin-angiotensin, and vasopressin systems all appear to be activated.

Full text

PDF
674

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenbrey G. A., Handelman W. A., Arnold P., Manning M., Schrier R. W. Vascular effects of arginine vasopressin during fluid deprivation in the rat. J Clin Invest. 1981 Apr;67(4):961–968. doi: 10.1172/JCI110146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnolda L., McGrath B., Cocks M., Sumithran E., Johnston C. Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res. 1985 Jun;19(6):378–382. doi: 10.1093/cvr/19.6.378. [DOI] [PubMed] [Google Scholar]
  3. Cowley A. W., Jr, Merrill D., Osborn J., Barber B. J. Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ Res. 1984 Feb;54(2):163–172. doi: 10.1161/01.res.54.2.163. [DOI] [PubMed] [Google Scholar]
  4. Cowley A. W., Jr, Monos E., Guyton A. C. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res. 1974 Apr;34(4):505–514. doi: 10.1161/01.res.34.4.505. [DOI] [PubMed] [Google Scholar]
  5. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  6. Elliott J. M., West M. J., Chalmers J. Effects of vasopressin on heart rate in conscious rabbits. J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):6–11. doi: 10.1097/00005344-198501000-00002. [DOI] [PubMed] [Google Scholar]
  7. Ferguson D. W., Abboud F. M., Mark A. L. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation. 1984 Mar;69(3):451–460. doi: 10.1161/01.cir.69.3.451. [DOI] [PubMed] [Google Scholar]
  8. Jaenke R. S., Deprez-DeCampeneere D., Trouet A. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit. Cancer Res. 1980 Oct;40(10):3530–3536. [PubMed] [Google Scholar]
  9. Johnston C. I. Vasopressin in circulatory control and hypertension. J Hypertens. 1985 Dec;3(6):557–569. doi: 10.1097/00004872-198512000-00001. [DOI] [PubMed] [Google Scholar]
  10. Kluger J., Cody R. J., Laragh J. H. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Am J Cardiol. 1982 May;49(7):1667–1674. doi: 10.1016/0002-9149(82)90244-2. [DOI] [PubMed] [Google Scholar]
  11. Korner P. I., Oliver J. R., Casley D. J. Effect of dietary salt on hemodynamics of established renal hypertension in the rabbit. Implications for the autoregulation theory of hypertension. Hypertension. 1980 Nov-Dec;2(6):794–801. doi: 10.1161/01.hyp.2.6.794. [DOI] [PubMed] [Google Scholar]
  12. Liard J. F., Spadone J. C. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):713–719. doi: 10.1097/00005344-198407000-00026. [DOI] [PubMed] [Google Scholar]
  13. Manning M., Lammek B., Kruszynski M., Seto J., Sawyer W. H. Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin. J Med Chem. 1982 Apr;25(4):408–414. doi: 10.1021/jm00346a015. [DOI] [PubMed] [Google Scholar]
  14. McGrath B. P., Lim S. P., Leversha L., Shanahan A. Myocardial and peripheral catecholamine responses to acute coronary artery constriction before and after propranolol treatment in the anaesthetised dog. Cardiovasc Res. 1981 Jan;15(1):28–34. doi: 10.1093/cvr/15.1.28. [DOI] [PubMed] [Google Scholar]
  15. Möhring J., Glänzer K., Maciel J. A., Jr, Düsing R., Kramer H. J., Arbogast R., Koch-Weser J. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):367–376. doi: 10.1097/00005344-198007000-00004. [DOI] [PubMed] [Google Scholar]
  16. Nicod P., Waeber B., Bussien J. P., Goy J. J., Turini G., Nussberger J., Hofbauer K. G., Brunner H. R. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1043–1047. doi: 10.1016/0002-9149(85)90743-x. [DOI] [PubMed] [Google Scholar]
  17. Pullan P. T., Johnston C. I., Anderson W. P., Korner P. I. Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension. Am J Physiol. 1980 Jul;239(1):H81–H87. doi: 10.1152/ajpheart.1980.239.1.H81. [DOI] [PubMed] [Google Scholar]
  18. Reid I. A., Schwartz J., Ben L., Maselli J., Keil L. C. Interactions between vasopressin and the renin--angiotensin system. Prog Brain Res. 1983;60:475–491. doi: 10.1016/S0079-6123(08)64414-3. [DOI] [PubMed] [Google Scholar]
  19. Riegger A. J., Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci (Lond) 1982 May;62(5):465–469. doi: 10.1042/cs0620465. [DOI] [PubMed] [Google Scholar]
  20. Riegger G. A., Liebau G., Bauer E., Kochsiek K. Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels. J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):1–5. doi: 10.1097/00005344-198501000-00001. [DOI] [PubMed] [Google Scholar]
  21. Riegger G. A., Liebau G., Kochsiek K. Antidiuretic hormone in congestive heart failure. Am J Med. 1982 Jan;72(1):49–52. doi: 10.1016/0002-9343(82)90576-9. [DOI] [PubMed] [Google Scholar]
  22. Schwartz J., Reid I. A. Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs. Endocrinology. 1981 Nov;109(5):1778–1780. doi: 10.1210/endo-109-5-1778. [DOI] [PubMed] [Google Scholar]
  23. Szatalowicz V. L., Arnold P. E., Chaimovitz C., Bichet D., Berl T., Schrier R. W. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med. 1981 Jul 30;305(5):263–266. doi: 10.1056/NEJM198107303050506. [DOI] [PubMed] [Google Scholar]
  24. Thomas J. A., Marks B. H. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978 Feb;41(2):233–243. doi: 10.1016/0002-9149(78)90162-5. [DOI] [PubMed] [Google Scholar]
  25. Undesser K. P., Hasser E. M., Haywood J. R., Johnson A. K., Bishop V. S. Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res. 1985 Mar;56(3):410–417. doi: 10.1161/01.res.56.3.410. [DOI] [PubMed] [Google Scholar]
  26. Woods R. L., Johnston C. I. Role of vasopressin in hypertension: studies using the Brattleboro rat. Am J Physiol. 1982 Jun;242(6):F727–F732. doi: 10.1152/ajprenal.1982.242.6.F727. [DOI] [PubMed] [Google Scholar]
  27. Zucker I. H., Share L., Gilmore J. P. Renal effects of left atrial distension in dogs with chronic congestive heart failure. Am J Physiol. 1979 Apr;236(4):H554–H560. doi: 10.1152/ajpheart.1979.236.4.H554. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES